Abstract
Autism Spectrum Disorder encompasses a range of neurodevelopmental disorders characterized by early deficits in social communication in addition to restricted and repetitive behaviors. Symptoms are increasingly understood to be associated with abnormalities in the coordination of neuronal assemblies responsible for processing information essential for early adaptive behaviors. Pharmacologic treatments carry evidence for clinically significant benefit of multiple impairing symptoms of ASD, yet these benefits are limited and range across a broad spectrum of medication classes, making it difficult to characterize associated neurochemical impairments. Increasing prevalence of both ASD and its pharmacologic management calls for greater understanding of the neurophysiologic basis of the disorder. This paper reviews underlying alterations in local brain regions and coordination of brain activation patterns during both resting state and task-related processes. We propose that new pharmacologic treatments may focus on realigning trajectories of network specialization across development by working in combination with behavioral treatments to enhance social and emotional learning by bolstering the impact of experience-induced plasticity on neuronal network connectivity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aman MG, Langworthy KS (2000) Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord 30(5):451–459
Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McCracken JT, Shah B, McMahon D (2005) Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry 162(7):1361–1369
American Psychological Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Publishing, Arlington
Arnold LE, Aman MG, Cook AM, Witwer AN, Hall KL, Thompson S, Ramadan Y (2006) Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 45(10):1196–1205
Ashwin C, Baron-Cohen S, Wheelwright S, O’Riordan M, Bullmore ET (2007) Differential activation of the amygdala and the ‘social brain’during fearful face-processing in Asperger Syndrome. Neuropsychologia 45(1):2–14
Assaf M, Jagannathan K, Calhoun VD, Miller L, Stevens MC, Sahl R, O’Boyle J, Schultz R, Pearlson GD (2010) Abnormal functional connectivity of default mode sub-networks in autism spectrum disorder patients. Neuroimage 53(1):247–256
Aylward EH, Minshew NJ, Field K, Sparks BF, Singh N (2002) Effects of age on brain volume and head circumference in autism. Neurology 59(2):175–183
Baron-Cohen S, Ring HA, Bullmore ET, Wheelwright S, Ashwin C, Williams SCR (2000) The amygdala theory of autism. Neurosci Biobehav Rev 24(3):355–364
Barttfeld P, Wicker B, Cukier S, Navarta S, Lew S, Sigman M (2011) A big-world network in ASD: dynamical connectivity analysis reflects a deficit in long-range connections and an excess of short-range connections. Neuropsychologia 49(2):254–263
Bernier R, Dawson G, Webb S, Murias M (2007) EEG mu rhythm and imitation impairments in individuals with autism spectrum disorder. Brain Cogn 64(3):228–237
Bird G, Catmur C, Silani G, Frith C, Frith U (2006) Attention does not modulate neural responses to social stimuli in autism spectrum disorders. Neuroimage 31(4):1614–1624
Blume WT (2006) Drug effects on EEG. J Clin Neurophysiol 23(4):306–311
Boeschoten MA, Kenemans JL, Engeland HV, Kemner C (2007) Abnormal spatial frequency processing in high-functioning children with pervasive developmental disorder (PDD). Clin Neurophysiol 118(9):2076–2088
Canive JM, Lewine JD, Edgar JC, Davis JT, Miller GA, Torres F, Tuason VB (1998) Spontaneous brain magnetic activity in schizophrenia patients treated with aripiprazole. Psychopharmacol Bull 34(1):101
Cardinale RC, Shih P, Fishman I, Ford LM, Müller RA (2013) Pervasive rightward asymmetry shifts of functional networks in Autism Spectrum Disorder. JAMA Psychiatry 70(9):975–982
Carper RA, Courchesne E (2005) Localized enlargement of the frontal cortex in early autism. Biol Psychiatry 57(2):126–133
Carrasco M, Volkmar FR, Bloch MH (2012) Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics 129(5):e1301–e1310
Casanova MF, van Kooten IA, Switala AE, van Engeland H, Heinsen H, Steinbusch HW, Hof P, Trippe J, Stone J, Schmitz C (2006) Minicolumnar abnormalities in autism. Acta Neuropathol 112(3):287–303
Castrén E (2013) Neuronal network plasticity and recovery from depression. JAMA Psychiatry 70(9):983–989
Center for Disease Control (2012) Prevalence of autism spectrum disorders–autism and developmental disabilities monitoring network, 14 Sites, United States, 2008
Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD, Chisum H, Courchesne RY (2001) Unusual brain growth patterns in early life in patients with autistic disorder an MRI study. Neurology 57(2):245–254
Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes C, Pierce K (2011) Neuron number and size in prefrontal cortex of children with autism. J Am Med Assoc 306(18):2001–2010
Dakin S, Frith U (2005) Vagaries of visual perception in autism. Neuron 48(3):497–507
Dalton KM, Nacewicz BM, Johnstone T, Schaefer HS, Gernsbacher MA, Goldsmith HH, Alexander A, Davidson RJ (2005) Gaze fixation and the neural circuitry of face processing in autism. Nat Neurosci 8(4):519–526
Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman M, Bookheimer SY, Iacoboni M (2005) Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 9(1):28–30
Dawson G, Jones EJ, Merkle K, Venema K, Lowy R, Faja S, Kamara D, Murias M, Greenson J, Winter J, Smith M, Rogers S, Webb SJ (2012) Early behavioral intervention is associated with normalized brain activity in young children with autism. J Am Acad Child Adolesc Psychiatry 51(11):1150–1159
Dawson G, Webb SJ, Carver L, Panagiotides H, McPartland J (2004) Young children with autism show atypical brain responses to fearful versus neutral facial expressions of emotion. Dev Sci 7(3):340–359
Dichter GS, Belger A (2007) Social stimuli interfere with cognitive control in autism. Neuroimage 35(3):1219–1230
Duffy FH, Als H (2012) A stable pattern of EEG spectral coherence distinguishes children with autism from neuro-typical controls-a large case control study. BMC Med 10(1):64
Dumont GJH, De Visser SJ, Cohen AF, Van Gerven JMA (2005) Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects. Br J Clin Pharmacol 59(5):495–510
Dupuy FE, Clarke AR, Barry RJ, McCarthy R, Selikowitz M (2010) EEG coherence in children with attention-deficit/hyperactivity disorder: differences between good and poor responders to methylphenidate. Psychiatry Res 180(2–3):114–119
Ecker C, Suckling J, Deoni S.C, Lombardo M.V, Bullmore E.T, Baron-Cohen S, Williams C (2012) Brain anatomy and its relationship to behavior in adults with autism spectrum disorder: a multicenter magnetic resonance imaging study. Arch Gen Psychiatry 69(2):195–209
Elbe D, Lalani Z (2012) Review of the pharmacotherapy of irritability in autism. J Can Acad Child Adolesc Psychiatry 21(2):130–146
Eyler LT, Pierce K, Courchesne E (2012) A failure of left temporal cortex to specialize for language is an early emerging and fundamental property of autism. Brain 135(Pt 3):949–960
Geschwind M, Pourtois G, Schwartz S, Van De Ville D, Vuilleumier P (2012) White-matter connectivity between face-responsive regions in the human brain. Cereb Cortex 22(7):1564–1576
Ghanbari Y, Bloy L, Edgar JC., Blaskey L, Verma R, Roberts TP (2013) Joint analysis of band-specific functional connectivity and signal complexity in autism. J. Autism Dev Disord 2(1):17
Gilbert SJ, Bird G, Brindley R, Frith CD, Burgess PW (2008) Atypical recruitment of medial prefrontal cortex in autism spectrum disorders: an fMRI study of two executive function tasks. Neuropsychologia 46(9):2281–2291
Gogtay N, Thompson PM (2010) Mapping gray matter development: implications for typical development and vulnerability to psychopathology. Brain Cogn 72(1):6–15
Gordon I, Vander Wyk BC, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA, Pelphrey KA (2013) Oxytocin enhances brain function in children with autism. Proc Nat Acad Sci U.S.A 110(52):20953–20958
Greenough WT, Black JE, Wallace CS (1987) Experience and brain development. Child Dev 58(3), 539–559
Grèzes J, Wicker B, Berthoz S, De Gelder B (2009) A failure to grasp the affective meaning of actions in autism spectrum disorder subjects. Neuropsychologia 47(8):1816–1825
Grice SJ, Halit H, Farroni T, Baron-Cohen S, Bolton P, Johnson MH (2005) Neural correlates of eye-gaze detection in young children with autism. Cortex 41(3):342–353
Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, Hickie IB (2010) Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 67(7):692–694
Hadjikhani N, Joseph RM, Snyder J, Chabris CF, Clark J, Steele S, McGrath L, Tager-Flusberg H (2004) Activation of the fusiform gyrus when individuals with autism spectrum disorder view faces. Neuroimage 22(3):1141–1150
Hamilton AF (2013) The mirror neuron system contributes to social responding. Cortex 49(10):2957–2959
Handen BL, Sahl R, Hardan AY (2008) Guanfacine in children with autism and/or intellectual disabilities. J Dev Behav Pediatr 29(4):303–308
Hardan AY, Libove RA, Keshavan MS, Melhem NM, Minshew NJ (2009) A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry 66(4):320–326
Harris JC, Carter CS (2013) Therapeutic interventions with oxytocin: current status and concerns. J Am Acad Child Adolesc Psychiatry 52(10):998–1000
Hellings JA, Zarcone JR, Reese RM, Valdovinos MG, Marquis JG, Fleming KK, Schroeder SR (2006) A crossover study of risperidone in children, adolescents and adults with mental retardation. J Autism Dev Disord 36(3):401–411
Herbert MR, Ziegler DA, Makris N, Filipek PA, Kemper TL, Normandin JJ, Caviness, VS (2004). Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 55(4):530–540
Hsia Y, Wong AY, Murphy DG, Simonoff E, Buitelaar JK, Wong, IC (2013) Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology 13:1–11
Hurwitz R, Blackmore R, Hazell P, Williams K, Woolfenden S (2012) Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents. Cochrane Database Syst Rev (3)
Hutsler JJ, Zhang H (2010) Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res 1309:83–94
Huttenlocher PR, Dabholkar AS (1997) Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387(2):167–178
Kennedy DP, Courchesne E (2008) The intrinsic functional organization of the brain is altered in autism. Neuroimage 39(4):1877–1885
Keown CL, Shih P, Nair A, Peterson N, Mulvey ME, Müller RA (2013) Local functional over connectivity in posterior brain regions is associated with symptom severity in autism spectrum disorders. Cell Rep 5(3):567–572
Kim E, Yu KS, Cho JY, Shin YW, Yoo SY, Kim YY, Jang I-J, Shin S-G, Kwon JS (2006) Effects of DRD2 and CYP2D6 genotypes on delta EEG power response to aripiprazole in healthy male volunteers: a preliminary study. Hum Psychopharmacol: Clin Exp 21(8):519–528
King BH, Wright D, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Cook EH Jr (2001) Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry 40(6):658–665
Kleinhans NM, Richards T, Sterling L, Stegbauer KC, Mahurin R, Johnson LC, Greenson J, Dawson G, Aylward E (2008) Abnormal functional connectivity in autism spectrum disorders during face processing. Brain 131(4):1000–1012
Kolevzon A, Mathewson KA, Hollander E (2006) Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry 67(3):407–414
Koshino H, Kana RK, Keller TA, Cherkassky VL, Minshew NJ, Just MA (2008) fMRI investigation of working memory for faces in autism: visual coding and underconnectivity with frontal areas. Cereb Cortex 18(2):289–300
Kylliäinen A, Braeutigam S, Hietanen JK, Swithenby SJ, Bailey AJ (2006) Face- and gaze-sensitive neural responses in children with autism: a magnetoencephalographic study. Eur J Neurosci 24(9):2679–2690
Lauvin MA, Martineau J, Destrieux C, Andersson F, Bonnet-Brilhault F, Gomot M, El-Hage W, Cottier JP (2012) Functional morphological imaging of autism spectrum disorders: current position and theories proposed. Diagn Interv Imaging 93(3):139–147
LeBlanc JJ, Fagiolini M (2011) Autism: a “critical period” disorder? Neural Plasticity 18(3):264–276
Liem-Moolenaar M, Rad M, Zamuner S, Cohen AF, Lemme F, Franson KL, van Gerven J, Pich EM (2011) Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men. Br J Clin Pharmacol 71(6):907–916
Lo YC, Soong WT, Gau SSF, Wu YY, Lai MC, Yeh FC, Chiang W-Y, Kuo L-W, Jaw F-S, Tseng WYI (2011) The loss of asymmetry and reduced interhemispheric connectivity in adolescents with autism: a study using diffusion spectrum imaging tractography. Psychiatry Res: Neuroimaging 192(1):60–66
Loo SK, Teale PD, Reite ML (1999) EEG correlates of methylphenidate response among children with ADHD: a preliminary report. Biol Psychiatry 45(12):1657–1660
Lopata C, Toomey JA, Fox JD, Thomeer ML, Volker MA, Lee GK (2013) Prevalence and predictors of psychotropic use in children with high-functioning ASDs. Autism Res Treat 103(5):881–888
Luby J, Mrakotsky C, Stalets MM ABelden A, Heffelfinger A, Williams M, Spitsnagel E (2006) Risperidone in preschool children with autistic spectrum disorders: An investigation of safety and efficacy. J Child Adolesc Psychopharmacol 16(5):575–587
Mahajan R, Bernal MP, Panzer R, Whitaker A, Roberts W, Handen B, Veenstra-VanderWeele J (2012) Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum Disorders. Pediatrics 130(Supplement 2):S125–S138
Malow B, Adkins KW, McGrew SG, Wang L, Goldman SE, Fawkes D, Burnette C (2012) Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord 42(8):1729–1737
Marcus RN, Owen R, Kamen L, Manos G, McQuade R, Carson WH, Aman MG (2009) A placebo-controlled fixed dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48(11):1110–1119
Marsh LE, Hamilton AFDC (2011) Dissociation of mirroring and mentalising systems in autism. Neuroimage 56(3):1511–1519
Martineau J, Andersson F, Barthélémy C, Cottier JP, Destrieux C (2010) Atypical activation of the mirror neuron system during perception of hand motion in autism. Brain Res 12(1320):168–175
McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, McMahon D (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347(5):314–321
Ming X, Gordon E, Kang N, Wagner GC (2008) Use of clonidine in children with autism spectrum disorders. Brain Dev 30(7):454–460
Miral S, Gencer O, Baykara B, Baykara A, Dirik E (2008) Risperidone versus haloperidol in children and adolescents with Autistic Disorder. Eur Child Adolesc Psychiatry 17(1):1–8
Mire SS, Nowell KP, Kubiszyn T, Goin-Kochel RP (2013) Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related? Autism
Monk CS, Peltier SJ, Wiggins JL, Weng SJ, Carrasco M, Risi S, Lord C (2009) Abnormalities of intrinsic functional connectivity in autism spectrum disorders. Neuroimage 47(2):764–772
Mottron L, Dawson M, Soulieres I, Hubert B, Burack J (2006) Enhanced perceptual functioning in autism: an update, and eight principles of autistic perception. J Autism Dev Disord 36(1):27–43
Mottron L, Mineau S, Martel G, Bernier CS, Berthiaume C, Dawson M, Faubert, J (2007) Lateral glances toward moving stimuli among young children with autism: early regulation of locally oriented perception? Dev Psychopathol 19(1):23–36
Murias M, Webb SJ, Greenson J, Dawson G (2007) Resting state cortical connectivity reflected in EEG coherence in individuals with autism. Biol Psychiatry 62(3):270–273
Murray M (2010) Attention-deficit/hyperactivity disorder in the context of autism spectrum disorders. Curr Psychiatry Rep 123(5):382–388
Nagaraj R, Singhi P, Malhi P (2006) Risperidone in children with autism: randomized, placebo-controlled, double-blind study. J Child Neurol 21(6):450–455
Nordahl CW, Scholz R, Yang X, Buonocore MH, Simon T, Rogers S, Amaral DG (2012) Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: a longitudinal study. Arch Gen Psychiatry 69(1):53–61
Oberman LM, Hubbard EM, McCleery JP, Altschuler EL, Ramachandran VS, Pineda JA (2005) EEG evidence for mirror neuron dysfunction in autism spectrum disorders. Cogn Brain Res 24(2):190–198
Ohnishi T, Matsuda H, Hashimoto T, Kunihiro T, Nishikawa M, Uema T, Sasaki M (2000) Abnormal regional cerebral blood flow in childhood autism. Brain 123(Pt 9):1838–1844
Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Findling RL (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124(6):1533–1540
Palmer CJ, Paton B, Hohwy J, Enticott PG (2013) Movement under uncertainty: the effects of the rubber-hand illusion vary along the nonclinical autism spectrum. Neuropsychologia 51(10):1942–1951
Pandina GJ, Bossie CA, Youssef E, Zhu Y, Dunbar F (2007) Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 37(2):367–373
Parikh MS, Kolevzon A, Hollander E (2008) Psychopharmacology of aggression in children and adolescents with autism: A critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol 18(2):157–178
Pinkham AE, Hopfinger JB, Pelphrey KA, Piven J, Penn DL (2008) Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr Res 99(1):164–175
Pringsheim T, Gorman D (2012) Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review. Can J Psychiatry 57(12):722–727
Redcay E, Courchesne E (2005) When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58(1):1–9
Rossignol DA, Frye RE (2013) Melatonin in Autism Spectrum Disorders. Curr Clin Pharmacol. [Epub ahead of print]
Schubart JR, Camacho F, Leslie D (2013) Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program. Autism. [Epub ahead of print]
Schulte-Rüther M, Markowitsch HJ, Fink GR, Piefke M (2007) Mirror neuron and theory of mind mechanisms involved in face-to-face interactions: a functional magnetic resonance imaging approach to empathy. J Cogn Neurosci 19(8):1354–1372
Schultz RT (2005) Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int J Dev Neurosci 23(2):125–141
Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N, Courchesne E (2010) Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci 30(12):4419–4427
Shafritz KM, Dichter GS, Baranek GT, Belger A (2008) The neural circuitry mediating shifts in behavioral response and cognitive set in autism. Biol Psychiatry 63(10):974–980
Sharma A, Shaw SR (2012) Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis. J Pediatric Health Care 26(4):291–299
Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114(5):e634–e641
Silberberg G, Gupta A, Markram H (2002) Stereotypy in neocortical microcircuits. Trends Neurosci 25(5):227–230
Simmons DR, Robertson AE, McKay LS, Toal E, McAleer P, Pollick FE (2009) Vision in autism spectrum disorders. Vision Res 49(22):2705–2739
Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA, Maravilla K, Dager SR (2002) Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59(2):184–192
Supekar K, Uddin LQ, Khouzam A, Phillips J, Gaillard WD, Kenworthy LE, Yerys B, Vaidya C, Menon V (2013) Brain hyperconnectivity in children with autism and its links to social deficits. Cell Reports 5(3):738–747
Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CE, Buitelaar JK, van Engeland H, Hoekstra PJ (2005) Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry 44(11):1137–1144
Uddin LQ, Superkar K, Lynch CJ, Khouzam A, Phillips J, Feinstein C et al (2013) Salience network based classification and prediction of symptom severity in children with autism. JAMA Psychiatry 70(8):869–879
Uddin LQ, Supekar K, Menon V (2010) Typical and atypical development of functional human brain networks: insights from resting-state FMRI. Frontiers Syst Neurosci 4(21)
Vidal CN, Nicolson R, DeVito TJ, Hayashi KM, Geaga JA, Drost DJ, Williamson P, Thompson PM (2006) Mapping corpus callosum deficits in autism: an index of aberrant cortical connectivity. Biol Psychiatry 60(3):218–225
Wang AT, Lee SS, Sigman M, Dapretto M (2007) Reading affect in the face and voice: neural correlates of interpreting communicative intent in children and adolescents with autism spectrum disorders. Arch Gen Psychiatry 64(6):698
Webb SJ, Dawson G, Bernier R, Panagiotides H (2006) ERP evidence of atypical face processing in young children with autism. J Autism Dev Disord 36(7):881–890
Webb S, Bernier R, Burner K, Murias M (2009) Electrophysiology and evoked potentials in autism research. In: Amaral D, Dawson G, Geschwind D (eds) Autism spectrum disorders. Oxford Library of Psychology, New York
Webb SJ, Jones EJ, Merkle K, Venema K, Greenson J, Murias M, Dawson G (2011) Developmental change in the ERP responses to familiar faces in toddlers with autism spectrum disorders versus typical development. Child Dev 82(6):1868–1886
Weng SJ, Carrasco M, Swartz JR, Wiggins JL, Kurapati N, Liberzon I, Monk CS (2011) Neural activation to emotional faces in adolescents with autism spectrum disorders. J Child Psychol Psychiatry 52(3):296–305
Williams JH, Whiten A, Singh T (2004) A systematic review of action imitation in autistic spectrum disorder. J Autism Dev Disord 34(3):285–299
Williams K, Wheeler DM, Silove N, Hazell P (2013) Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Syst Rev (8)
Williams JH, Waiter GD, Gilchrist A, Perrett DI, Murray AD, Whiten A (2006) Neural mechanisms of imitation and ‘mirror neuron’functioning in autistic spectrum disorder. Neuropsychologia 44(4):610–621
Wolff JJ, Gu H, Gerig G, Elison JT, Styner M, Gouttard S, Botteron K, Piven J (2012) Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry 169(6):589–600
Won H, Mah W, Kim E (2013) Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Mol Neurosci 6(19)
Wong TK, Fung PC, Chua SE, McAlonan GM (2008) Abnormal spatiotemporal processing of emotional facial expressions in childhood autism: dipole source analysis of event-related potentials. Eur J Neurosci 28(2):407–416
Wright B, Sims D, Smart S, Alwazeer A, Alderson-Day B, Allgar V, Whitton C, Miles J (2011) Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord 41(2):175–184
Acknowledgment
Support for this project was provided to Dr. Webb by the National Institutes of Health (R01-HD064820, R01-MH10028, HHSN271201200005I).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kodish, I., Rockhill, C.M., Webb, S.J. (2014). ASD: Psychopharmacologic Treatments and Neurophysiologic Underpinnings. In: Kumari, V., Bob, P., Boutros, N. (eds) Electrophysiology and Psychophysiology in Psychiatry and Psychopharmacology. Current Topics in Behavioral Neurosciences, vol 21. Springer, Cham. https://doi.org/10.1007/7854_2014_298
Download citation
DOI: https://doi.org/10.1007/7854_2014_298
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12768-2
Online ISBN: 978-3-319-12769-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)